Literature DB >> 32413515

Procleave: Predicting Protease-specific Substrate Cleavage Sites by Combining Sequence and Structural Information.

Fuyi Li1, Andre Leier2, Quanzhong Liu3, Yanan Wang1, Dongxu Xiang4, Tatsuya Akutsu5, Geoffrey I Webb6, A Ian Smith7, Tatiana Marquez-Lago8, Jian Li9, Jiangning Song10.   

Abstract

Proteases are enzymes that cleave and hydrolyse the peptide bonds between two specific amino acid residues of target substrate proteins. Protease-controlled proteolysis plays a key role in the degradation and recycling of proteins, which is essential for various physiological processes. Thus, solving the substrate identification problem will have important implications for the precise understanding of functions and physiological roles of proteases, as well as for therapeutic target identification and pharmaceutical applicability. Consequently, there is a great demand for bioinformatics methods that can predict novel substrate cleavage events with high accuracy by utilizing both sequence and structural information. In this study, we present Procleave, a novel bioinformatics approach for predicting protease-specific substrates and specific cleavage sites by taking into account both their sequence and 3D structural information. Structural features of known cleavage sites were represented by discrete values using a LOWESS data-smoothing optimization method, which turned out to be critical for the performance of Procleave. The optimal approximations of all structural parameter values were encoded in a conditional random field (CRF) computational framework, alongside sequence and chemical group-based features. Here, we demonstrate the outstanding performance of Procleave through extensive benchmarking and independent tests. Procleave is capable of correctly identifying most cleavage sites in the case study. Importantly, when applied to the human structural proteome encompassing 17,628 protein structures, Procleave suggests a number of potential novel target substrates and their corresponding cleavage sites of different proteases. Procleave is implemented as a webserver and is freely accessible at http://procleave.erc.monash.edu/.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cleavage site prediction; Conditional random field; Machine learning; Protease; Structural determinants

Year:  2020        PMID: 32413515     DOI: 10.1016/j.gpb.2019.08.002

Source DB:  PubMed          Journal:  Genomics Proteomics Bioinformatics        ISSN: 1672-0229            Impact factor:   7.691


  19 in total

1.  Deep Learning-Based Advances In Protein Posttranslational Modification Site and Protein Cleavage Prediction.

Authors:  Subash C Pakhrin; Suresh Pokharel; Hiroto Saigo; Dukka B Kc
Journal:  Methods Mol Biol       Date:  2022

2.  As in Real Estate, Location Matters: Cellular Expression of Complement Varies Between Macular and Peripheral Regions of the Retina and Supporting Tissues.

Authors:  Randy Zauhar; Josef Biber; Yassin Jabri; Mijin Kim; Jian Hu; Lew Kaplan; Anna M Pfaller; Nicole Schäfer; Volker Enzmann; Ursula Schlötzer-Schrehardt; Tobias Straub; Stefanie M Hauck; Paul D Gamlin; Michael B McFerrin; Jeffrey Messinger; Christianne E Strang; Christine A Curcio; Nicholas Dana; Diana Pauly; Antje Grosche; Mingyao Li; Dwight Stambolian
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

3.  Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases.

Authors:  Andrew Chang; Xinyu Xiang; Jing Wang; Carolyn Lee; Tamta Arakhamia; Marija Simjanoska; Chi Wang; Yari Carlomagno; Guoan Zhang; Shikhar Dhingra; Manon Thierry; Jolien Perneel; Bavo Heeman; Lauren M Forgrave; Michael DeTure; Mari L DeMarco; Casey N Cook; Rosa Rademakers; Dennis W Dickson; Leonard Petrucelli; Michael H B Stowell; Ian R A Mackenzie; Anthony W P Fitzpatrick
Journal:  Cell       Date:  2022-03-04       Impact factor: 66.850

4.  Constructing and evaluating caspase-activatable adeno-associated virus vector for gene delivery to the injured heart.

Authors:  Mitchell J Brun; Kefan Song; Byunguk Kang; Cooper Lueck; Weitong Chen; Kaitlyn Thatcher; Erhe Gao; Walter J Koch; Joy Lincoln; Sudarsan Rajan; Junghae Suh
Journal:  J Control Release       Date:  2020-11-04       Impact factor: 9.776

Review 5.  Large-scale comparative review and assessment of computational methods for anti-cancer peptide identification.

Authors:  Xiao Liang; Fuyi Li; Jinxiang Chen; Junlong Li; Hao Wu; Shuqin Li; Jiangning Song; Quanzhong Liu
Journal:  Brief Bioinform       Date:  2021-07-20       Impact factor: 11.622

6.  iFeatureOmega: an integrative platform for engineering, visualization and analysis of features from molecular sequences, structural and ligand data sets.

Authors:  Zhen Chen; Xuhan Liu; Pei Zhao; Chen Li; Yanan Wang; Fuyi Li; Tatsuya Akutsu; Chris Bain; Robin B Gasser; Junzhou Li; Zuoren Yang; Xin Gao; Lukasz Kurgan; Jiangning Song
Journal:  Nucleic Acids Res       Date:  2022-05-07       Impact factor: 19.160

7.  VARIDT 2.0: structural variability of drug transporter.

Authors:  Tingting Fu; Fengcheng Li; Yang Zhang; Jiayi Yin; Wenqi Qiu; Xuedong Li; Xingang Liu; Wenwen Xin; Chengzhao Wang; Lushan Yu; Jianqing Gao; Qingchuan Zheng; Su Zeng; Feng Zhu
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

8.  Porpoise: a new approach for accurate prediction of RNA pseudouridine sites.

Authors:  Fuyi Li; Xudong Guo; Peipei Jin; Jinxiang Chen; Dongxu Xiang; Jiangning Song; Lachlan J M Coin
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 13.994

9.  NonClasGP-Pred: robust and efficient prediction of non-classically secreted proteins by integrating subset-specific optimal models of imbalanced data.

Authors:  Chao Wang; Jin Wu; Lei Xu; Quan Zou
Journal:  Microb Genom       Date:  2020-11-27

10.  Identification of Disease-Related 2-Oxoglutarate/Fe (II)-Dependent Oxygenase Based on Reduced Amino Acid Cluster Strategy.

Authors:  Jian Zhou; Suling Bo; Hao Wang; Lei Zheng; Pengfei Liang; Yongchun Zuo
Journal:  Front Cell Dev Biol       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.